Complexin activates Ca
2+
-sensor synaptotagmin. The N-terminal domain of complexin is important for activation, but its molecular mechanism is still poorly understood. Here, we observed that a split pair of N-terminal and central domain fragments of complexin is sufficient to activate Ca 2+ -triggered release using a reconstituted single-vesicle fusion assay, suggesting that the N-terminal domain acts as an independent module within the synaptic fusion machinery. The N-terminal domain can also interact independently with membranes, which is enhanced by a cooperative interaction with the neuronal SNARE complex. We show by mutagenesis that membrane binding of the N-terminal domain is essential for activation of Ca 2+ -triggered fusion. Consistent with the membrane-binding property, the N-terminal domain can be substituted by the influenza virus hemagglutinin fusion peptide, and this chimera also activates Ca (1, 2) . Synaptic vesicle fusion is orchestrated by the neuronal soluble N-ethylmaleimidesensitive factor attachment protein receptor (SNARE) fusion proteins (3, 4) , in conjunction with synaptotagmin, complexin, and other synaptic proteins. The Ca 2+ -sensor synaptotagmin is essential for Ca 2+ -triggered release (5) (6) (7) (8) . Neuronal SNARE proteins form a ternary complex consisting of synaptobrevin/vesicle-associated membrane protein (VAMP2), syntaxin, and synaptosomal-associated protein . The main isoform synaptotagmin-1 is involved in synchronous release, and forms a conserved Ca 2+ -independent interface with the ternary SNARE complex (9) , along with Ca 2+ -dependent interactions with the plasma membrane, and potentially other interfaces with the SNARE complex (10) . Complexin is a small cytosolic α-helical protein abundant in the presynaptic terminal (11) that interacts with the SNARE complex (12) and the membrane (13) .
Complexin has at least two functions: It "activates" (i.e., greatly enhances) Ca 2+ -triggered synchronous neurotransmitter release by cooperating with synaptotagmin, and it regulates spontaneous release in the presynaptic terminal (recently reviewed in refs. [14] [15] [16] . The activating function of complexin is conserved across all species (mammals, Drosophila, and Caenorhabditis elegans) and different types of Ca 2+ -triggered synaptic vesicle fusion studied to date (11, (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) . Complexin also regulates spontaneous neurotransmitter release, although this effect is less conserved among species and varies depending on experimental conditions: for example, in Drosophila, spontaneous release increases with knockout of complexin (27, 28) . Likewise, knockdown of complexin in cultured cortical neurons increases spontaneous release, although knockout of complexin in mice only affects spontaneous release depending on the particular neuronal cell type (20, 23, 24, 29) . Exactly how complexin can exhibit these dual effects on Ca 2+ -triggered and spontaneous synaptic vesicle fusion remains enigmatic; however, it is known that different domains of complexin play different roles in Ca 2+ -triggered and spontaneous vesicle fusion, as summarized in the following paragraphs.
Here, we focus on the complexin-1 isoform (referred to as Cpx in the following). Cpx can be divided into four domains (Fig. 1A , Bottom) that are involved in different functions. The N-terminal domain (residues 1-27) of Cpx is important for activation of synchronous Ca 2+ -triggered release in murine neurons (20, 30, 31) and in isolated chromaffin cells (32) . However, N-terminal truncation of Cpx in C. elegans neuromuscular junctions does not decrease Ca 2+ -triggered release, but rather increases spontaneous release (21, 22) , perhaps suggesting that reduction of activation may have been masked by a simultaneous increase of spontaneous fusion in these previous experiments.
Manipulation or elimination of the accessory domain (residues 28-48) affects the regulation of spontaneous synaptic vesicle fusion in both neurons and reconstituted systems (20, 29, 30, (33) (34) (35) (36) (37) (38) . Although the accessory domain is required for regulating Significance Synaptic neurotransmitter release is an essential process for communication between neurons. Neurotransmitter release occurs upon an action potential, resulting in a local Ca 2+ -concentration increase in the presynaptic terminal that triggers synaptic vesicle membrane fusion with the plasma membrane. Synaptic vesicle fusion is orchestrated by neuronal soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs), synaptotagmin, complexin, and other factors. Here, we found that the complexin N-terminal domain binds to membranes and that it can be substituted with the fusion peptide of influenza virus hemagglutinin, resulting in similar activation of Ca 2+ -triggered fusion as wild-type complexin in a reconstituted vesicle fusion system. We conclude that similar fusion elements and principles are used in different contexts of biological membrane fusion.
spontaneous release, mutations of this domain do not affect the activating function of Cpx for Ca 2+ -triggered release compared with wild-type neurons in rescue experiments of Cpx knockdown (23, 39) .
The central domain of Cpx (residues 49-70) is essential for all functions of complexins in all species studied to date, including priming (23, 24, 39, 40) , inhibiting spontaneous release (18, 20-22, 35, 37, 38) , and activation of Ca 2+ -triggered release (17, 18, 20, 22, 30, 31, 35, 41) .
The C-terminal domain binds to phospholipids (24, 42) , and it is important for vesicle priming in neurons (24, 32, 43) . Moreover, Cpx without the C-terminal domain does not reduce spontaneous release in neuronal cultures, but it still activates Ca 2+ -triggered release in neuronal cultures (24) and in a reconstituted system (35) . The C-terminal domain is sensitive to membrane curvature, and it may thus localize Cpx to the synaptic membrane (13, 44) .
Structurally, in isolation, both the N-and C-terminal domains of Cpx are largely flexible, although the accessory and central domains have α-helical propensity (45) . The α-helical central domain of Cpx binds to the groove between the synaptobrevin-2 and syntaxin-1A α-helices in the center of the neuronal SNARE complex (12, 46) . Cpx has two conformations when bound to the ternary SNARE complex, one of which induces a conformational change at the membrane-proximal C-terminal end of the ternary SNARE complex that specifically depends on the N-terminal, accessory, and central domains of Cpx (47) .
Cpx has been studied extensively with reconstituted systems (35, 38, (48) (49) (50) (51) (52) . The single-vesicle fusion assay described by Lai et al. (35) qualitatively reproduced the effects of synaptotagmin-1 and Cpx in both spontaneous and Ca
-triggered release that have been observed in cortical neuronal cultures (9, 35) .
Here, we conducted single-vesicle fusion and single-molecule membrane-binding experiments to obtain new insights into the function of the Cpx N-terminal domain. We found that the N-terminal domain can be physically separated from the accessory and central domains of Cpx and still preserve its role in activating Ca 2+ -triggered release. The N-terminal domain interacts with membranes, an interaction that is enhanced by the presence of SNARE complex. Moreover, the N-terminal domain of full-length Cpx can be functionally substituted by the fusion peptide of influenza virus hemagglutinin (HA), suggesting that similar fusion elements and principles are used in different contexts of biological membrane fusion.
Results
The Accessory-Central Fragment Is a Minimal Unit for Suppressing Spontaneous Fusion. We used a single-vesicle fusion assay to monitor individual spontaneous and Ca
2+
-triggered fusion events (35) (Fig. 1A and Methods). Two types of vesicles were reconstituted: vesicles with reconstituted syntaxin-1A and SNAP-25A that mimic the plasma membrane (referred to as "PM vesicles") and vesicles with reconstituted synaptobrevin-2 and synaptotagmin-1 that mimic synaptic vesicles (referred to as "SV vesicles"). The PM vesicles were tethered on a passivated surface, SV vesicles were added and incubated in the absence or presence of Cpx or specified fragments for a 1-min period, and unbound SV vesicles were then removed. Subsequently, spontaneous fusion was monitored for a 1-min period, followed by injection of 500 μM Ca 2+ , and Ca
-triggered fusion was monitored for an additional 1-min period.
The analysis of these fusion experiments includes the SV/PM vesicle association count (Fig. 1B) , the average probability of spontaneous fusion per second in the absence of Ca 2+ ("spontaneous fusion"; Fig. 1C ), the probability of Ca 2+ -triggered fusion during the first 1-s time bin upon Ca 2+ injection ("amplitude"; Fig.  1D ), and the decay rate of the fusion histogram upon Ca 2+ injection ("synchronization"; Fig. 1E ) (Methods). The fusion probabilities and amplitudes were normalized with respect to the corresponding number of analyzed SV/PM vesicle pairs (Table S1 and Figs. S1 and S2). Thus, the normalized fusion probabilities and amplitudes provide information about fusion of associated SV/PM vesicles, independent of the number of associated vesicle pairs. This normalization is a major advantage of our single-vesicle method compared with bulk fusion assays, which cannot distinguish between effects that are due to vesicle association or fusion itself (53) .
Wild-type Cpx [Cpx (1-134)] reduced spontaneous fusion, whereas the C-terminally truncated Cpx (1-86) fragment did not, compared with the control without Cpx (Fig. 1C) , consistent with previous results (35) . However, upon deletion of both N-and C-terminal domains, the remaining accessory-central fragment Cpx (26-83) reduced spontaneous fusion similar to wild-type Cpx (Fig. 1C ). Both Cpx (1-134) and Cpx (1-86) significantly increased the amplitude (Fig. 1D) , as well as the synchronization of Ca 2+ -triggered fusion (Fig. 1E) , compared with the control without Cpx, again consistent with previous observations (35) . In contrast, Cpx (26-83) did not increase the amplitude and the synchronization of Ca 2+ -triggered fusion compared with the control without Cpx (Fig. 1 D and E) , consistent with the Spontaneous fusion E Normalized probability (Table S1 ). The error bars in E are error estimates computed from the covariance matrix upon fitting the corresponding histograms with a single exponential decay function using the Levenberg-Marquardt algorithm. *P < 0.05 using the Student's t test, compared with the control experiment without Cpx (black bars).
requirement of the N-terminal domain for activation of Ca 2+ -triggered fusion in murine neurons (20, 30, 31) and isolated chromaffin cells (32) . 2+ -triggered fusion, we tested if the function of the N-terminal domain could be restored by addition as a noncovalently linked fragment. We generated four Cpx fragments and tested their effects on both spontaneous and Ca
-triggered fusion in isolation and as pairs of fragments ( Fig. 2A) . The split fragment pair Cpx and reduced spontaneous fusion similar to wild-type levels (Fig. 2C) , whereas the split fragment pair Cpx (1-47) and (48-83) was unable to do so. Thus, the accessory domain must be covalently linked to the central domain of Cpx to reduce spontaneous release, consistent with the notion that the accessory domain of Cpx suppresses or regulates spontaneous fusion in conjunction with the central domain (29, 33, 34, 37, 38) .
Both split fragment pairs Cpx and and Cpx and activated Ca 2+ -triggered fusion regardless of the disposition of the accessory domain: They approximately doubled the effect of wild-type Cpx on the amplitude and also slightly increased synchronization (Fig. 2 D and E) . Moreover, the split pair Cpx and (covering the entire sequence of Cpx) reduced spontaneous fusion (Fig. 2C ) and activated Ca 2+ -triggered fusion ( Fig. 2 D and E) . In summary, the N-terminal domain of Cpx can be split from the rest of the molecule, and the split pair constructs activate Ca 2+ -triggered fusion more than wild-type Cpx. Complete elimination of the accessory domain resulted in the inability of the split fragment pair Cpx and to reduce spontaneous fusion compared with wild-type Cpx (Fig.  2C) , consistent with mutation studies of the accessory domain (so-called "poor-clamp" and "no-clamp" mutations) (33, 38, 39, 54) . Remarkably, this split fragment pair without the accessory domain still activated Ca 2+ -triggered fusion more than wild-type Cpx, similar to the split fragment pairs that included the accessory domain (Fig. 2 D and E) . Thus, complete elimination of the accessory domain still allows Cpx to activate Ca 2+ -triggered release, going beyond mutation studies of the accessory domain in neurons (39) .
The Cpx N-Terminal Domain Binds to Membranes and SNAREs Enhance
This Interaction. The Cpx N-terminal domain is intrinsically disordered on its own as inferred from NMR (31) and circular dichroism (CD) spectroscopy studies (Fig. S3A) . Even when combined with the Cpx accessory domain, the N-terminal domain is still largely disordered (Fig. S3B) . On the other hand, the Cpx N-terminal domain interacts with the membrane-proximal (C-terminal) end of the ternary SNARE complex as assessed by NMR spectroscopy of either 15 N isotope-labeled Cpx or ternary SNARE complex (31) . Moreover, it has been suggested that the N-terminal domain forms an amphipathic α-helix upon binding to the ternary SNARE complex, although no structure of the complex is available that includes the Cpx N-terminal domain.
To test directly if SNARE binding to the Cpx N-terminal domain enhances the interaction of the N-terminal domain with a membrane, we fluorescently labeled the Cpx (1-47) fragment at residue A44 for single-molecule membrane-binding experiments (Fig. 3A) . We observed binding of labeled Cpx (1-47) fragments to protein-free liposomes with the same lipid composition as PM vesicles [i.e., similar to the plasma membrane, including phosphatidylserine (PS), phosphatidylethanolamine (PE), phosphatidylinositol 4,5-bisphosphate (PIP2), and cholesterol] (Fig. 3B , Upper Left). In contrast, the Cpx (26-83) fragment (i.e., without the N-terminal domain) did not significantly bind to liposomes at all (Fig. 3B , Lower Left).
For quantitative analysis, the distribution of the numbers of labeled Cpx fragments bound to liposomes was fit to a Poisson distribution (Fig. 3B , blue curves). We then derived a Poisson distribution that includes both labeled and unlabeled Cpx fragments that are bound to liposomes (Fig. 3B , red curves and Methods). We calculated the average number of bound Cpx (1-47) fragments (both labeled and unlabeled) per liposome ( Fig.  3C ), as well as the probability that a liposome has any bound Cpx fragment (Fig. 3D ). The Cpx (1-47) fragment bound to liposomes with 10% probability (Fig. 3D) .
Addition of the soluble part of the ternary SNARE complex (Methods) roughly doubled the probability of Cpx (1-47) binding to liposomes (Fig. 3D) , consistent with the notion that interaction of the Cpx N-terminal domain with the membrane-proximal (C-terminal) end of the ternary SNARE complex induces a conformation of the Cpx N-terminal domain that is more likely to bind to the membrane (31) . The N-terminal domain is required for this enhanced membrane binding because the Cpx (26-83) fragment without N-terminal domain showed very little binding to liposomes in the absence or presence of soluble SNARE complex ( Fig. 3 B-D) . 
Cpx [1-26] & [26-134]
Accessory Central C-term. (Table S1 ). The error bars in E are error estimates computed from the covariance matrix upon fitting the corresponding histograms with a single exponential decay function using the LevenbergMarquardt algorithm. *P < 0.05; **P < 0.01 using the Student's t test, compared with the control experiment without Cpx (black bars).
Membrane Binding of the Cpx N-Terminal Domain Is Required for
Function. We wanted to test if membrane binding of the Cpx N-terminal domain is required for activation of Ca 2+ -triggered fusion. Primary sequence comparison for the Cpx N-terminal domain among its orthologs and paralogs revealed multiple conserved hydrophobic residues (Fig. 4A) , which are likely to contribute in membrane binding. Based on this alignment, we designed a Cpx mutant that replaced three conserved hydrophobic amino acid residues with acidic amino acid residues [F3D, V4E, and L9E; referred to as Cpx (1-47) 3M ] (Fig. 4A) . Indeed, the Cpx (1-47) 3M mutant significantly abolished the ability of Cpx N-terminal domain to bind to membranes (Fig. S4) . Moreover, the split fragment pair Cpx (1-47) 3M and (48-83) did not activate Ca (Fig. 4) , we tested if the N-terminal domain of Cpx can be replaced with other fusogenic elements that are known to interact with membranes. As an example, the HA fusion peptide interacts with the host membrane, forming an extended conformation at low pH and a helical hairpin at neutral pH (55) (56) (57) . The membrane interaction of the HA fusion peptide assists HA to promote membrane fusion upon a pH dropinduced conformational change of the initially extended HA trimer (58, 59) . Fusion requires engagement of three to four neighboring HA trimers that collectively overcome the high kinetic barrier for lipid bilayer fusion (60, 61) . When the total free energy provided by HA fold-back events is higher than the free energy (62) required to overcome the hydration force barrier of membrane merger (63), fusion occurs.
To test our hypothesis that the N-terminal domain of Cpx can be functionally replaced by a membrane-binding fusion peptide, we created a chimera between the HA fusion peptide and Cpx (D) Bar graphs show the binding probability between Cpx fragments and liposomes in the absence or presence of SNARE complex. The binding probability was calculated as described in Methods. Error bars are SDs from 10 random imaging locations in the same sample channel. **P < 0.01; ***P < 0.001 using the Student's t test, compared with the experiment with Cpx (1-47) A44C (white bars). 
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Normalized probability The bar graphs show the effects of the specified Cpx fragments at 2 μM concentration on the SV/PM vesicle association count during the first acquisition periods (Methods) (C), the average probability of spontaneous fusion events per second (D), the amplitude of the first 1-s time bin (probability of a fusion event in that bin) upon Ca 2+ injection (E), and the decay rate (1/τ) of the histogram upon Ca 2+ injection (F). The fusion probabilities and amplitudes were normalized with respect to the corresponding number of analyzed SV/PM vesicle pairs (Methods). Individual histograms are in Figs. S1 and S2. The error bars in C-E are SDs for multiple independent repeat experiments ( Table S1 ). The error bars in F are error estimates computed from the covariance matrix upon fitting the corresponding histograms with a single exponential decay function using the Levenberg-Marquardt algorithm. **P < 0.01 using the Student's t test, compared with the control experiment without Cpx (black bars). (Fig. 5A) . Remarkably, the HA/Cpx chimera behaved similar to wild-type Cpx in our assay: It reduced spontaneous fusion and activated Ca 2+ -triggered fusion, although both the amplitude and synchronization were somewhat increased compared with wild-type Cpx (Fig. 5 C-E) .
Cpx split fragment pairs
We next tested if the HA/Cpx chimera can be split into two fragments similar to wild-type Cpx (Fig. 5A) . Because the HA fusion peptide itself is insoluble, it can only be studied in solution when it is fused to a peptide sequence that makes it soluble (56) . We therefore used a chimera of the HA fusion peptide and the Cpx accessory domain [HA/Cpx ] that solubilizes the HA fusion peptide and has α-helical propensity (Fig. S3C ). When combined with the central domain Cpx , this split fragment pair activated Ca 2+ -triggered release above and beyond the split fragment pair Cpx (1-47) and (Fig. 5 D and E) .
The HA fusion peptide itself is not expected to interact with the SNARE complex. However, the Cpx accessory domain interacts with partially assembled ternary SNARE complex (33, 37, 38) as well as binary (syntaxin-1A/SNAP-25A) complex (47) , so this interaction should localize the HA/Cpx (29- (Fig. S5) .
Discussion

Cpx activates Ca
2+
-triggered neurotransmitter release and regulates spontaneous release in neurons (22, 41, 54) . This dual role led to the hypothesis that Cpx clamps fusion before Ca 2+ triggering, whereas synaptotagmin subsequently releases the Cpx clamp upon Ca 2+ binding (37, 38, 64, 65) . However, more recent results suggest that the mechanisms of regulation of spontaneous fusion and activation of Ca 2+ -triggered fusion are distinct (35, 54) . Moreover, mutations of the accessory domain of Cpx that disrupt the ability to suppress spontaneous fusion have no effect on evoked release (39) . Finally, mechanisms of spontaneous fusion and synchronous fusion may involve different Ca 2+ sensors and/or different vesicle pools in neurons (66) .
Modularity of Cpx Domains. Our results show that the two functions of Cpx are physically separable by splitting Cpx into two separate fragments (Fig. 2) . Single vesicle fusion experiments with split fragment pairs of Cpx suggest that the N-terminal and central domains are independently functional modules that can act without covalent linkage and still activate Ca 2+ -triggered release. In contrast, the accessory domain has to be linked to the Cpx central domain in order to reduce spontaneous fusion (Fig. 2C) .
The accessory-central fragment Cpx (26-83) (i.e., without both N-and C-terminal domains) reduces spontaneous fusion similar to wild-type Cpx (Fig. 1C) . The longer Cpx (1-86) fragment substantially reduced the number of associated SV/PM vesicle pairs compared with the control without Cpx (Fig. 1B) . Therefore, the Cpx (1-86) fragment somehow interferes with SV/PM vesicle association and with suppression of spontaneous fusion, so we did not consider it any further.
The Accessory Domain Is Not Essential for Activation of Ca 2+ -Triggered Fusion by Cpx. The accessory domain is required for regulation of spontaneous release both in reconstituted systems and in neurons (33, 38, 39, 54) . Consistent with these previous results, elimination of the accessory domain also resulted in the inability of the split fragment pair Cpx and to reduce spontaneous fusion in our single-vesicle fusion assay (Fig.  2C) . Nevertheless, mutations of the accessory domain have no effect on the activating function of Cpx for Ca 2+ -triggered release in neurons (39) . Going beyond these earlier studies, we discovered that the accessory domain can be entirely eliminated and still maintain the activating function of Cpx [split fragment pair Cpx (1-26) and in Fig. 2 D and E] . We conclude that a "clamp-release" mechanism of the accessory domain is not necessary for activation of Ca 2+ -triggered fusion. The four split fragment pairs all roughly doubled the Ca 2+ -triggered amplitude and also slightly increased synchronization (right four bars in Fig. 2 D and E) compared with wild-type Cpx. This larger activation could be related to the increased conformational space of these fragment pairs compared with full-length Cpx: In the absence of a covalent linkage, the N-terminal domain may be more readily available to interact with the partially folded trans SNARE complex, setting the stage for activating Ca (Fig. 3) . We note that the relatively low binding probability of Cpx (1-47) to membranes (Table S1 ). The error bars in E are error estimates computed from the covariance matrix upon fitting the corresponding histograms with a single exponential decay function using the Levenberg-Marquardt algorithm. *P < 0.05; **P < 0.01; ***P < 0.001 using the Student's t test, compared with the control experiment without Cpx (black bars).
(10%; Fig. 3D ), along with differences in lipid composition, might explain the absence of significant chemical shifts in previous NMR experiments (31) . The Cpx N-terminal membrane-binding probability is roughly doubled in the presence of soluble SNARE complex (Fig. 3D) , consistent with the notion that binding to the SNARE complex induces a conformation of the Cpx N-terminal domain that is more likely to interact with the membrane (31) .
Membrane binding of the Cpx N-terminal domain is essential because disruption of membrane binding abolished the activating function of Cpx (Fig. 4) . On the other hand, the interaction of the Cpx N-terminal domain with the ternary SNARE complex is also important because it enhances the membrane-binding probability of the N-terminal domain (31) . Recent single-molecule studies have revealed that the interaction between the Cpx N-terminal domain and the ternary SNARE complex induces a conformational change in the membrane-proximal (C-terminal) end of the fully assembled ternary SNARE complex (47) . In these experiments, the induction of the conformational change required the presence of the Cpx accessory domain as well. However, we have shown here that the accessory domain is entirely dispensable for activation of Ca 2+ -triggered fusion. These observations can be reconciled by postulating that the interaction of the Cpx N-terminal domain occurs with the trans SNARE complex that is juxtaposed between the membranes (Fig. 6 ) regardless of the accessory domain. In contrast when starting from fully assembled ternary SNARE complex, both the accessory and N-terminal domains are required to induce the observed conformational change at the C-terminal end of the SNARE complex (47) . (Fig. 5 C-E), demonstrating that the N-terminal domain of Cpx can be functionally replaced by the HA fusion peptide. We also performed experiments with split fragment pairs involving the HA fusion peptide. Because the HA fusion peptide itself is not well behaved, and it is not expected to interact with the SNARE complex, we linked the HA fusion peptide to the accessory domain of Cpx, HA/Cpx . The interaction between the accessory domain and a trans SNARE complex (33) is expected to localize HA/Cpx to the sites of membrane fusion. Indeed, the split fragment pair HA/Cpx and Cpx (48-83) also activated Ca 2+ -triggered fusion (Fig. 5 D and E) , whereas an accessory domain mutant of this chimera that abolishes interaction with the trans SNARE complex did not (Fig. S5) . Moreover, this split fragment pair did not suppress spontaneous fusion because the accessory domain is not attached to the central domain of Cpx.
Concerted Action of the Cpx N-Terminal and Central Domains for
Activation. The N-terminal domain on its own is insufficient to activate Ca 2+ -triggered fusion, even when it is combined with the Cpx accessory domain (Fig. 2 D and E) . On the other hand, the Cpx central domain on its own does not activate Ca 2+ -triggered fusion either (Fig. 2 D and E) . Activation only occurs when both the N-terminal and central domains are combined, although covalent linkage is not required.
For Ca 2+ -triggered SV fusion, we propose an extension of our previous model of an assembled prefusion complex before the arrival of Ca 2+ (9) . In this extended model, the N-terminal domain of Cpx interacts with both the membrane-proximal end of the trans SNARE complex and the plasma membrane near the fusion site (Fig. 6) . Upon Ca 2+ binding to synaptotagmin-1, multiple membrane interactions may trigger a number of processes (9), including full zippering of the SNARE complex (4), membrane insertion of the Ca 2+ -binding loops of the C2B domain of synaptotagmin-1 (67, 68) , and membrane bending induced by synaptotagmin-1 (69, 70) . In addition, the synaptotagmin-1/SNARE complex could undergo a dynamic change (10).
The actions of each of the three membrane interaction, remodeling, and fusion elements (SNARE complex, Ca 2+ -bound synaptotagmin-1 C2B, and Cpx N-terminal domain) would contribute certain fractions of the total free energy (62) required for membrane fusion. The high cooperativity and speed of Ca 2+ -triggered neurotransmitter release would be achieved via this synergistic mechanism.
Methods
Protein Purification and Labeling. We used the same constructs and protocols to purify SNAP-25A, synaptotagmin-1, Cpx (1-134; i.e., full-length Cpx), Cpx , and Cpx (1-86) as previously described (35) . The protein sample concentrations were measured by UV absorption at 280 nm, and aliquots were flash frozen in liquid nitrogen and stored at −80°C.
Syntaxin-1A and synaptobrevin-2/VAMP2 were expressed as an N-terminal 6× histidine-tagged construct with a tobacco etch virus (TEV) cleavage site in C43 (DE3) cells. Cells were lysed by three passes through an Emulsiflex C5 homogenizer (Avestin) at 15,000 psi. Cell debris and inclusion bodies were removed by centrifugation at 10,000 rpm in a Beckman JA-14 rotor (Beckman Coulter) for 10 min. The supernatant was then centrifuged at 10,000 rpm for 10 min in the same rotor. Membranes were collected by centrifugation at 40,000 rpm in a Beckman Coulter Ti-45 rotor for 2 h. Membranes were washed by homogenization in 360 mL of buffer containing 20 mM Hepes (pH 7.5), 1 mM tris(2-carboxyethyl)phosphine (TCEP), and 10% (wt/vol) glycerol supplemented with two EDTA-free complete protease inhibitor mixture tablets. Membranes were harvested again by centrifugation in a Ti-45 rotor at 40,000 rpm for 1 h. The pellet was resuspended in 100 mL of buffer containing 20 mM Hepes (pH 7.5), 500 mM NaCl, 1 mM TCEP, 10 mM imidazole, 1 mM PMSF, and 10% (wt/vol) glycerol supplemented with two EDTA-free complete protease inhibitor mixture tablets and frozen in two 50-mL aliquots in liquid nitrogen. One aliquot of membranes was solubilized in the presence of 2% (wt/vol) n-dodecyl-beta-maltoside (DDM) for 1 h at 4°C. The extract was clarified by centrifugation in a Ti-45 rotor at 40,000 rpm for 35 min. The supernatant was bound to a 1-mL bed volume of nickel-nitrilotriacetic acid (NTA) beads (Qiagen) equilibrated in buffer containing 20 mM Hepes (pH 7.5), 500 mM NaCl, 1 mM TCEP, 10 mM imidazole, 1 mM PMSF, 10% (wt/vol) glycerol, and 1.5% DDM by stirring at 4°C for 1 h. Beads were harvested by centrifugation and poured into a column; attached to an AKTA Prime system; washed with 50 mL of buffer containing 20 mM Hepes (pH 7.5), 300 mM NaCl, 1 mM TCEP, 20 mM imidazole, 10% (wt/vol) glycerol, and 110 mM octylbeta-glucoside (OG); and then eluted with the same buffer containing 450 mM imidazole and 1 M NaCl. Protein-containing fractions were combined and injected on a Superdex 200 (10/300GL) column equilibrated in 20 mM Hepes C-term. 6 . Model of the prefusion state of the SNARE/synaptotagmin/Cpx supercomplex. We propose that the Ca 2+ sensitivity, cooperativity, and high speed of SV fusion are achieved by the synergistic actions of synaptotagmin-1-SNARE membrane interactions (9), membrane bending (69, 70) , full zippering of the ternary SNARE complex (4), and interaction of the Cpx N-terminal (term.) domain with the membrane (Fig. 3 ) and the SNARE complex (31).
(pH 7.5), 300 mM NaCl, 1 mM TCEP, 110 mM OG, and 10% (wt/vol) glycerol. Peak fractions of concentration greater than 40 μM for syntaxin-1A and 80 μM for synaptobrevin-2 were then combined, and 100 μg of TEV protease (GE Healthcare) was added to cleave the tag for 45 min at ambient temperature, after which the reaction was complete and the TEV protease had precipitated. TEV removal was done by centrifugation for 10 min at 5,000 rpm in a tabletop centrifuge 5804 R (Eppendorf). The protein sample concentrations were measured by UV absoprtion at 280 nm, and aliquots were flash frozen in liquid nitrogen and stored at −80°C.
Cpx (1-26) was synthesized by Genscript with purity higher than 95%. The Cpx (1-47) A44C, Cpx (1-47) 3M A44C, Cpx (26-83) A44C, Cpx (1-47) 3M , HA/Cpx , and HA/Cpx (29-49) no-clamp constructs were cloned by QuikChange (Agilent). The sequence of HA fusion peptide used to replace the Cpx N-terminal domain (Fig. 5A) is GLFGAIAGFIENGWEGMIDGWYGF.
Cpx (48-83), Cpx (1-47), Cpx (1-47) 3M , Cpx (1-47) 44C, and Cpx (1-47) 3M A44C were expressed with an N-terminal 6× histidine tag, followed by a thrombin cleavage site in BL21 (DE3) cells. The induced cell pellet was resuspended in 50 mM Tris (pH 8.0) and 8 M urea, and then lysed via three passes through an Emulsiflex C5 homogenizer at 15,000 psi. The lysate was clarified by centrifugation in a Beckman JA-20 rotor for 30 min at 18,000 rpm. The supernatant was bound to 2 mL of nickel-NTA agarose (Qiagen) for 1 h at room temperature. The resin was washed with 75 mL of 50 mM Tris (pH 8.0) and 8 M urea at room temperature and eluted with the same buffer containing 300 mM imidazole. Protein-containing fractions were combined and dialyzed against 20 mM Tris (pH 8.0), 50 mM NaCl, and 1 M urea overnight at 4°C in a 2,000 molecular weight cutoff dialysis cassette. The sample was removed from the cassette, and 200 μg of thrombin protease (Sigma-Aldrich) was added to remove the 6× histidine tag for 30 min at room temperature. A second digest was performed, 1 mM PMSF was added to quench the thrombin activity, and then the cleaved protein was injected through a 0.22-μM filter onto a MonoS (5/50) [for Cpx (48-83)] or MonoQ (5/50) [for Cpx and its mutants] ion exchange column equilibrated in 20 mM Tris (pH 8.0) and 50 mM NaCl. The protein was eluted by running a linear NaCl gradient from 50 mM to 1 M over 20 column volumes. Protein-containing fractions were combined, the concentration of Cpx (48-83) was measured by UV absorption at 280 nm, and the concentrations of Cpx (1-47) and its mutants were measured by Bradford assay and SDS-gel electrophoresis, and aliquots were flash frozen in liquid nitrogen and stored at −80°C.
Cpx and Cpx (26-83) 44C were expressed as N-terminal GST fusion proteins. Induced cells were resuspended in 50 mM Hepes (pH 7.5), 300 mM NaCl, 1 mM EDTA, and 2 mM DTT (buffer A) containing one protease inhibitor tablet per 50-mL buffer. Cells were lysed by three passes through an Emulsiflex C5 homogenizer at 15,000 psi. The lysate was clarified by centrifugation in a Ti-45 rotor for 35 min at 40,000 rpm. The supernatant was bound to 10 mL of GST Sepharose (GE Healthcare) at 4°C for 1 h. The beads were washed with 100 mL of buffer A containing 1 M NaCl and then with 50 mL of buffer A to remove the high salt. The beads were then resuspended in 10 mL of buffer A, and 700 μg of PreScission (GE Healthcare) protease was added to cleave the Cpx from the GST tag overnight at 4°C. Cleaved Cpx (26-83) was injected onto a Superdex 75 (10/300) size exclusion column (GE Healthcare) equilibrated in 25 mM Tris (pH 7.5), 300 mM NaCl, and 0.5 mM TCEP. Proteincontaining fractions were combined. The concentration was measured by UV absorption at 280 nm. Aliquots were flash frozen in liquid nitrogen and stored at −80°C.
The HA/Cpx, HA/Cpx , and HA/Cpx (29-49) no-clamp constructs were purified under denaturing conditions. Briefly, the cell pellets were resuspended in 50 mM Tris (pH 8.0), and 8 M urea (buffer B). Cells were lysed by three passes through an Emulsiflex C5 homogenizer at 15,000 psi. The lysate was clarified by centrifugation in a type Ti-45 rotor for 35 min at 40,000 rpm. The supernatant was bound to 2 mL of nickel-NTA agarose for 1 h at room temperature, followed by washing with 60 mL of buffer B; the sample was then eluted with buffer A containing 300 mM imidazole. Protein-containing fractions were dialyzed against 20 mM Tris (pH 8.0), 50 mM NaCl, and 1 M urea overnight at 4°C. One hundred twenty-five micrograms of PreScission protease and 4 mM DTT were added to the protein sample and incubated at room temperature for 1 h. The cleaved protein was injected on a MonoQ (5/50) ion exchange column (GE Healthcare) equilibrated in 20 mM Tris (pH 8.0) and 50 mM NaCl, washed, and eluted in a linear NaCl gradient from 50 to 500 mM over 30 column volumes. Protein-containing fractions were combined, the protein sample concentrations were measured by UV absorption at 280 nm, and aliquots were flash frozen in liquid nitrogen and stored at −80°C.
The "soluble" ternary SNARE complex containing rat SNAP-25 (range: 7-83 aa), SNAP-25A (range: 141-204 aa), the cytoplasmic domain of syntaxin-1A (range: 191-256 aa), and the His-tagged cytoplasmic domain of synaptobrevin-2 (range: 28-89 aa) was cloned with the Duet expression system (Novagen). The complex was expressed in Escherichia coli BL21(DE3) cells at 30°C overnight using autoinducing LB. Details of the purification protocol are provided by Zhao et al. (71) . The purified complex is referred to as SNARE complex in Fig. 3 .
PM and SV Vesicles. The reconstitution method for PM and SV vesicles is described in detail by Kyoung et al. (72) . We used the same membrane compositions and protein densities as in our previous studies (35, 50) . SV vesicles contained both reconstituted synaptotagmin-1 and synaptobrevin-2, whereas PM vesicles contained reconstituted syntaxin-1A and SNAP-25A. For SV vesicles, the lipid composition was phosphatidylcholine (PC; 48%), PE (20%), PS (12%), and cholesterol (20%). For PM vesicles, the lipid composition was Brain Total Lipid Extract (Avanti Polar Lipids, Inc.) supplemented with 3 mol% PIP2, and 0.1 mol% biotinylated PE. Quantitative 31 P NMR analysis (Avanti Polar Lipids Inc.) of two different stocks of Brain Lipid Extract revealed the following average composition of the major components: 17% PC, 8% PE, 14% plasmalogen PE, 8% PS, and sphingomyelin (5%). Among the remaining 48% of other components of Brain Total Lipid Extract is at least 20% cholesterol (73) ; thus, at variance with the previously published protocol (72), cholesterol was not additionally supplemented. Dried lipid films were dissolved in 110 mM OG buffer containing purified proteins at protein-to-lipid ratios of 1:200 for synaptobrevin-2 and syntaxin-1A, and at a protein-to-lipid ratio of 1:800 for synaptotagmin-1. A threefold to fivefold excess of SNAP-25A (with respect to syntaxin-1A) and 3.5 mol% PIP2 were added to the protein-lipid mixture for PM vesicles only. Detergent-free buffer [20 mM Hepes (pH 7.4), 90 mM NaCl, and 0.1% 2-mercaptoethanol] was added to the protein-lipid mixture until the detergent concentration was at (but not lower than) the critical micelle concentration of 24.4 mM (i.e., vesicle did not yet form). For the preparation of SV vesicles, 50 mM sulforhodamine B (Invitrogen) was added to the protein-lipid mixture. The vesicles subsequently formed during size exclusion chromatography using a Sepharose CL-4B column, packed under near-constant pressure by gravity with a peristaltic pump (GE Healthcare) in a 5.5-mL column with a 5-mL bed volume, that was equilibrated with buffer V [20 mM Hepes (pH 7.4), 90 mM NaCl, 20 μM EGTA, and 0.1% 2-mercaptoethanol]. The eluent was subjected to dialysis into 2 L of detergent-free buffer V supplemented with 5 g of Bio-beads SM2 and 0.8 g/L Chelex 100 resin. After 4 h, the buffer was exchanged with 2 L of fresh buffer V containing Bio-beads, and the dialysis was continued for another 12 h (overnight). We note that for SV vesicles, the chromatography equilibration and elution buffers did not contain sulforhodamine; thus, the effective sulforhodamine concentration inside SV vesicles is considerably (up to 10-fold) lower than 50 mM.
As described previously (49) , the presence and purity of reconstituted proteins were confirmed by SDS/PAGE of the vesicle preparations, and the directionality of the membrane proteins (facing outward) was assessed by chymotrypsin digestion followed by SDS/PAGE. The size distributions of the SV and PM vesicles were analyzed by cryo-EM, as described previously (50) .
Single-Vesicle Content Mixing Assay. To monitor SV/PM vesicle association, spontaneous fusion, and Ca
2+
-triggered fusion, we used the single-vesicle content mixing assay described by Lai et al. (35) . The surface of the quartz slides was passivated by coating the surface with polyethylene glycol (PEG) molecules, which alleviated nonspecific binding of vesicles. The same protocol and quality controls (surface coverage and nonspecific binding) were used as described previously (72, 74) , except that PEG-SVA (Laysan Bio), instead of mPEG-SCM (Laysan Bio), was used because it has a longer t 1/2 . The surface was functionalized by inclusion of biotin-PEG (Laysan Bio) during pegylation. A quartz slide was assembled into a flow chamber and incubated with neutravidin (0.1 mg/mL). Biotinylated PM vesicles (diluted 100-fold) were tethered by incubation at ambient temperature (25°C) for 30 min, followed by three rounds of washing with 120 μL of buffer V, to remove unbound PM vesicles; each buffer wash effectively replaces the (3-μL) flow chamber volume more than 100-fold (Fig. 1A) . Upon the start of illumination and recording of the fluorescence from a particular field of view of the flow chamber, SV vesicles (diluted 100-to 1,000-fold, depending on the acquisition round as discussed below) were loaded into the flow chamber and association of SV with PM vesicles was monitored for 1 min. Cpx, Cpx fragments, or Cpx-chimeras were added concurrently, together with the SV vesicles, at 2 μM concentration. While continuing the recording, the flow chamber was washed three times (120 μL of buffer V and including the Cpx, Cpx fragments, or Cpx-chimeras at 2 μM concentration) to remove unbound SV vesicles. Subsequently, we continued recording for 1 min to monitor spontaneous fusion events. Thus, in contrast to a previous version of this assay where SV vesicles were incubated with tethered PM vesicles for at least 30 min (49), monitoring of fusion events was started right after the 1-min SV/PM vesicle association period and buffer washes. Subsequently, Ca 2+ solution, consisting of 500 μM Ca 2+ and 500 nM Cy5 dye molecules (used as an indicator for the arrival of Ca 2+ in the evanescent field), as well as Cpx, Cpx fragments, or Cpx chimeras at 2 μM concentration in buffer V, was injected into the flow chamber. Ca 2+ -triggered fusion events were monitored within the same field of view upon injection for a 1-min period. The injection was performed at a speed of 66 μL·s −1 by a motorized syringe pump (Harvard Apparatus) using a withdrawal method similar to the one described previously (35, 50) . All experiments were carried out at ambient temperature (25°C).
Multiple Acquisition Rounds and Repeats for the Fusion Experiments. To increase the throughput of the assay and make better use of the vesicle samples, after intensive washing (3 × 120 μL) with buffer V (which includes 20 μM EGTA to remove Ca 2+ from the sample chamber), we repeated the entire acquisition sequence (SV vesicle loading, counting the number of associated SV/PM vesicles, monitoring of spontaneous fusion, Ca 2+ injection, and monitoring of Ca 2+ -triggered fusion) in a different imaging area within the same flow chamber. Five such "acquisition rounds" were performed with the same sample chamber. SV vesicles were diluted 1,000-fold for the first and second acquisition rounds, 200-fold for the third and fourth acquisition rounds, and 100-fold for the fifth acquisition round to offset the slightly increasing saturation of the surface with SV vesicles. The entire experiment (each with five acquisition rounds) was then repeated n times (Table S1 ) using different flow chambers (referred to as "repeat experiments"). Among the specified number of repeats there are at least three different protein preps and vesicle reconstitutions, so the variations observed in the bar charts reflect sample variations as well as variations among different flow chambers.
Instrument Setup for the Fusion Experiments. All experiments were performed on a prism-type total internal reflection fluorescence microscope using 532-nm (green) laser (CrystaLaser) excitation. Two observation channels were created by a 640-nm, single-edge, dichroic beamsplitter (FF640-FDi01-25×36, Shemrock): One channel was used for the fluorescence emission intensity of the content dyes, and the other channel was used for the fluorescence emission intensity of the Cy5 dyes that are part of the injected Ca 2+ solution. The two channels were recorded on two adjacent rectangular areas (45 × 90 μm 2 ) of a chargecoupled device camera (iXon+ DV 897E; Andor Technology USA). The imaging data were recorded with smCamera software developed by Taekjip Ha, Johns Hopkins University, Baltimore. Our procedure resulted in a time series of images over a total of 3 min, consisting of the subsequent 1-min periods of vesicle association, spontaneous fusion, and Ca 2+ -triggered fusion, plus 5-s intervals for buffer exchanges. The arrival time of Ca 2+ was determined by monitoring of the Cy5 channel.
Data Analysis of the Fusion Experiments. We detected content dye fluorescent spots in a particular imaging area with the smCamera program written by Taekjip Ha. The appearance of a content dye fluorescence spot corresponds to an association of an SV vesicle to a surface-tethered PM vesicle. However, only those spots were subsequently analyzed and counted that showed exactly one stepwise increase of the fluorescence intensity during the SV/PM vesicle association period of 1 min that precedes the subsequent fusion periods (Fig.  1A) . Thus, this procedure excludes SV vesicles that underwent spontaneous fusion during the vesicle association period because fusion leads to a second stepwise fluorescence intensity increase. Moreover, for data acquisition rounds within the same sample chamber, this procedure excludes SV vesicles that were already associated during a previous acquisition round. Stepwise increases in the fluorescence intensity time traces were automatically detected by the computer program described by Kyoung et al. (72) and Diao et al. (75) , and were manually checked to ensure correct performance of the automated procedure. Collectively, we refer to this selected set of content dye fluorescent spots as the "analyzed SV/PM vesicle pairs."
In the subsequent spontaneous and Ca 2+ -triggered fusion periods of 1 min each, a second stepwise increase in content dye fluorescence intensity was counted as a spontaneous fusion event and a Ca 2+ -triggered fusion event,
respectively. Histograms for spontaneous and Ca 2+ -triggered fusion event occurrence were then generated with a time bin of 1 s. Ca 2+ -triggered fusion histograms were synchronized by the appearance of fluorescence intensity of the Cy5 dye molecules that are part of the injected Ca 2+ solution. Histograms were cumulated over all acquisition rounds and repeat experiments. The cumulated histograms were subsequently normalized by dividing the histograms by the total number of analyzed SV/PM vesicle pairs for a particular condition (i.e., the sum of the number of analyzed SV/PM vesicle pairs for all acquisition rounds and repeat experiments for a particular condition) (Figs. S1 and S2 and Table S1 ).
In the bar charts in Figs. 1, 2, 4 , and 5 and Fig. S5 , the "vesicle association count" refers to the number of associated SV/PM vesicle pairs only during the first acquisition round, averaged over all repeat experiments for a particular condition. We only used the first acquisition round for the vesicle association count because the imaging surface becomes progressively saturated in subsequent rounds such that a small number of vesicle association events may be missed in these subsequent rounds. The average probability of spontaneous fusion events per second is calculated by dividing the overall spontaneous fusion probability of the cumulated and normalized histograms during the 1-min observation period by 60. The amplitude is the probability of Ca 2+ -triggered fusion in the cumulated and normalized histograms during the first time bin (1 s) upon Ca 2+ injection. The error bars for the probabilities and amplitudes were calculated as SDs for the n repeat experiments (Table S1 ) by using individually cumulated (but globally normalized) histograms for all rounds of a particular repeat experiment. The histograms of the Ca 2+ -triggered fusion probability (Fig. S2 ) were fit to a single exponential decay function using the Levenberg-Marquardt algorithm. The degree of synchronization was described by the decay rate, and error bars for the decay rate were obtained from the covariance matrix of the fit. Single-Molecule Cpx Membrane-Binding Assay. Quartz slides were prepared using the same protocol as described above for the single-vesicle content mixing assay. Protein-free liposomes with the same lipid composition as PM vesicles containing 0.5% 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI) were tethered on the PEG-coated surface. The average diameter of these liposomes is 80 nm. After removing unbound vesicles, 1 μM Alexa 647-labeled Cpx (1-47) A44C, Cpx (26-83) A44C, or Cpx (1-47) 3M A44C fragments were injected with or without 1 μM soluble SNARE complex into the flow chamber and incubated for 30 min at room temperature. After rinsing away unbound proteins using oxygen scavenger buffer (0.1 mg/mL glucose oxidase, 0.02 mg/mL catalase, 0.4 wt% β-D-glucose, and 0.1% cyclooctatetraene), DiI vesicle and Alex 647-Cpx were simultaneously excited by green (532 nm) and red (632 nm) laser light. The number of the labeled Cpx fragments that colocalized with DiI vesicles in the imaging area (45 × 90 μm where λ is the average number of bound Cpx fragments per liposome and A is the total number of liposomes (also called "frequency" of a Poisson distribution). We refer to this function as the "visible" Poisson distribution function:
To calculate the "real" Poisson distribution function that includes both labeled and unlabeled Cpx fragments, we assume that both labeled and unlabeled Cpx fragments have the same binding affinity to membrane. With the known labeling efficiency η [∼30% for both Cpx (1-47) and Cpx (26-83) fragments], we obtain
xf r ðx; A r , λ r Þ.
Thus, the real distribution function can be obtained by solving the above equation for A r :
f r = f r ðx; A r , λ r Þ.
The number of unlabeled Cpx fragments that are bound to the liposomes (N inv ) is N inv = f v ð0; A v , λ v Þ − f r ð0; A r , λ r Þ.
The average number of bound Cpx fragments (Fig. 3C) per liposome is calculated as P ∞ x=0 xf r ðx; A r , λ r Þ P ∞ x=0 f r ðx; A r , λ r Þ = P ∞ x=0 xf r ðx; A r , λ r Þ A r .
The probability of binding of Cpx fragments to any liposome (Fig. 3D) is calculated as
where n = 10 is the total number of imaging areas [fields of view (FOV)] that were randomly selected within the same quartz slide channel, and N FOV is the average number of liposomes observed in each imaging area.
CD Spectroscopy. The CD spectra were measured with an AVIV stop-flow CD spectropolarimeter at 200-250 nm using a cell with a 1-mm path length. The sample containing 0.25 mg/mL Cpx (1-26), Cpx (1-47), or HA/Cpx in PBS buffer [137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , and 2 mM KH 2 PO 4 (pH 7.4)] was measured at 20°C. For the correction of the baseline error, the signal from a blank run with PBS buffer was subtracted from all of the experimental spectra.
